6-K 1 a2135462z6-k.htm 6-K
QuickLinks -- Click here to rapidly navigate through this document



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934

For the month of April, 2004

Commission File Number: 001-10378

AVENTIS
(Translation of registrant's name into English)

67917 Strasbourg CEDEX 9
France
(Address of principal executive offices)

        Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F    ý        Form 40-F    o

        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):    o

        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):    o

        Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes    o        No    ý

        If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable





Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    AVENTIS
(Registrant)

Date: April 30, 2004

 

By:

/s/  
DIRK OLDENBURG      
Name: Dirk Oldenburg
Title: General Legal Counsel

2



EXHIBIT LIST

Exhibit

  Description
99.1   Transcript from Aventis' First Quarter 2004 Results conference call held on April 29, 2004.
99.2   Transcript from Aventis' First Quarter 2004 Results U.S. conference call held on April 29, 2004.
99.3   Press Release, dated April 1, 2004, relating to the completion of Aventis' divestment of Aventis Behring.
99.4   Press Release, dated April 1, 2004, relating to the FDA's denial of Public Citizen Petition regarding Arava.
99.5   Press Release issued by Aventis on April 26, 2004.



QuickLinks

Signatures
EXHIBIT LIST